Navigation Links
Researchers Create Embryonic-Like Stem Cells From Human Testes
Date:10/8/2008

Finding could sidestep ethical concerns surrounding use of cells from embryos

WEDNESDAY, Oct. 8 (HealthDay News) -- European researchers say they've figured out how to coax sperm-producing testicular cells into embryonic-like stem cells.

The findings are the latest in a flurry of published research that seeks to duplicate embryonic stem cell behavior and biology while sidestepping the political and ethical obstacles associated with their use.

"The ability to make a pluripotent stem cell from an individual without the ethical and immunological problems associated with human embryonic stem cells is a big deal," said Peter J. Donovan,, a stem cell expert at the University of California, Irvine.

The new research was published online Oct. 8 in the journal Nature.

Thomas Skutella of the University of Tubingen in Germany and his colleagues used testicular tissue from 22 men to create what they call "germline stem cells." Essentially, they collected these tissues, isolated the cells that give rise to sperm cells, and then cultured them in growth media containing factors that support the development of human embryonic stem cells. Within a few weeks, the cells took on many of the genetic and growth characteristics of embryonic stem cells.

At the genetic level, for instance, the new cells were more like embryonic stem cells than sperm cells. When injected into immune-compromised mice, they produced teratomas, a tumor that contains many different kinds of cells. When grown in culture dishes, the new cells could be directed to differentiate into muscle, bone, neurons, and pancreatic tissues, the study authors said.

"My summary is, it is a nice paper, they made big progress in getting to a pluripotent cell, and they show pluripotency with a teratoma experiment," said Dr. Gerd Hasenfuss of the University of Gottingen, Germany, who has published papers on converting mouse sperm cells into stem
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
4. Bipolar disorder relapses halved by Melbourne researchers
5. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
6. High and mighty: first common height gene identified by researchers behind obesity gene finding
7. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
8. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
9. Researchers develop long-lasting growth hormone
10. Jefferson immunology researchers halt lethal rabies infection in brain
11. Purdue researchers develop technology to detect cancer by scanning surface veins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...holders to be held on January 8, 2009 , , T... International Inc. ("MedEmerg") (OTCBB: MDER), on..., announced today that it has obtained an interim ...oncerning its previously announced plan of arrange...lth Group Inc. ("AIM") will acquire all of MedEmer...
(Date:11/21/2008)...he University of Texas Health Science Center at Ho...ce in Aging Studies (TEXAS), to promote geriatrics...million award from the Donald W. Reynolds Foundati...ll allow us to teach geriatric medicine principles...to practicing physicians. With the reach of Lyndon...
(Date:11/21/2008)... Heska Corporation,(Nas...he New York Society of,Security Analysts, 12th An...ecember 2, 2008 at 1177 Avenue of the Americas, 2n...duled to begin at 9:35 a.m. Eastern Time (7:35 a.m...ebcast and for two weeks,following the presentati...
(Date:11/21/2008)... The Generic,Pharmaceut...tement today from,GPhA President and CEO Kathleen...TC) roundtable on "Emerging Health Care Competitio...at the FTC is conducting this roundtable demonstra...sumers have access to safe and,affordable biogene...
Breaking Medicine News(10 mins):Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4Health News:GPhA Statement on FTC Roundtable on Biogenerics 2
...A new study suggests that children with hemophilia...ses joint pain and swelling, are more at risk // ... their later years. But there is hope in preventi...dren, say researchers. Hemophiliac children are no...
...Eighty percent of the time childhood acute lymphob...bad news is doctors are not sure // why it doesn’...new research finds it could be because of a small ...rugs used to treat the disease. Researchers teste...
...A new study finds MRIs are significantly better at...ping cancers than standard mammograms // or clinic...omen with a lifetime breast cancer risk of 15 perc...so carried one of the genes known to put women at ...
...Moms-to-be have one more good reason not to smoke....ing during the early months // of pregnancy increa...e study, involved women from Scotland and England ...ere about six months old. Researchers asked about ...
Other Medicine News:
(Date:11/20/2008)... WASHINGTON, Nov. 20 T...h & Gender Equity: , , WHAT: World AI... , Tuesday, November 25, 2008 , 11:00 a.m. E...trongly encouraged: https://cc.readytalk.com/r/1x...ions outpacing the number of people newly put on t...
(Date:11/20/2008)... , , , , PHILADELPHIA, Nov. 20 /P...K ) today announced that the United States Food an...proval for PROMACTA(R) (eltrombopag) for the treat...immune (idiopathic) thrombocytopenic purpura (ITP)...teroids, immunoglobulins or splenectomy. The appro...
(Date:11/20/2008)... REINACH, Switzerland, November 20 /PRNewswir...y that the Anti-infective Drugs Advisory Committee...as voted 17 to 2 against the,approval of intraven...nt for,the treatment of patients with complicated...luding those caused by methicillin-resistant Staph...
(Date:11/20/2008)... EMERYVILLE, Calif., Nov. 20 /PRNewswire-FirstCal...he company will present results from the Phase 1B,...dvanced metastatic breast,cancer, BZL101, at the ...onal,Conference in Atlanta, Georgia. The Company...g abstract and will be presented as a part of the ...
Breaking Medicine Technology:Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Minnesota Reaches Milestone in Goal to End Homelessness 28155 1Minnesota Reaches Milestone in Goal to End Homelessness 28155 2NovoLogix Launches First Annual Symposium for Healthcare Thought Leaders 28151 1NovoLogix Launches First Annual Symposium for Healthcare Thought Leaders 28151 2NovoLogix Launches First Annual Symposium for Healthcare Thought Leaders 28151 3Men are better at detecting infidelities 5647 1Men are better at detecting infidelities 5647 2Women at Higher Risk for Pulmonary Hypertension 28144 1Women at Higher Risk for Pulmonary Hypertension 28144 2
...FORT LEE, N.J.--(BUSINESS WIRE)--Jun 21, 2007 - Ne...blication in the June 23 issue,of the journal The ...e therapy trial for Parkinson,s disease and the fi...s own brain cells for any adult,neurodegenerative ...in 12 patients with,advanced Parkinson,s disease d...
..."Electroloading of mature dendritic cells with tum...ponse", GAITHERSBURG, Md., and YOKOHAMA, Japan, Ju...net Co., Ltd. announce a,joint poster presentation...ociety for Cellular Therapy. The meeting is being,...presentation is entitled "Electroloading of mature...
Other Medicine Technology:Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 2Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 3Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 4Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 5Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 6MaxCyte and Medinet to Present at the 13th Annual Meeting of the,International Society for Cellular Therapy (ISCT) in Sydney,Australia 2MaxCyte and Medinet to Present at the 13th Annual Meeting of the,International Society for Cellular Therapy (ISCT) in Sydney,Australia 3
This is adapted to microplate or card.
ScanGel® Incubator
The ID-Micro Typing System™ (ID-MTS) Gel Test is suitable for a broad range of blood bank applications. Applications that include antibody screening and identification, ABO blood grouping and R
...Mini-Vertical Gel System simplifies the process of...AGE format. It is able to run four gels at a time,...tility and throughput, the 120 mini-vertical runs ...120 mini-vertical has a modular design. The basic ...
Medicine Products: